Singular Bio, Inc. — Form D

Singular Bio, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-15. The offering totals $8.0M, of which $6.6M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2019-02-15
• Form: D
• Accession: 0001768097-19-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $8.0M
• Amount sold: $6.6M
• Remaining: $1.4M
• Minimum investment: $1
• Investors: 8
• Date of first sale: 2019-01-31
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-333003

Issuer

• Name: Singular Bio, Inc.
• CIK: 0001768097
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 455 MISSION BAY BLVD. SOUTH, SUITE 145, SAN FRANCISCO, CA, 94158
• Phone: 415-553-8773

Officers, directors & promoters (3)

More

• CIK 1768097 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search